Who
Susan Bobulsky
Chief Commercial Officer, MRD
Company insider
Files Form 4 as: Chief Commercial Officer, MRD, Adaptive Biotechnologies.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $4.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Aug 2020
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $193K6,444 at $30.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $32K1,195 at $27.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $32K1,195 at $27.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $75K3,000 at $25.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $75K3,000 at $25.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $31K1,299 at $24.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $31K1,299 at $24.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $115K5,000 at $23.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $115K5,000 at $23.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $11K487 at $22.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $11K487 at $22.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $103K5,000 at $20.50 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $103K5,000 at $20.50 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $95K5,000 at $19.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $95K5,000 at $19.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $198K11,000 at $18.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $198K11,000 at $18.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $544K41,338 at $13.17 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $544K41,338 at $13.17 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —59,375 at $0.00 | filing |
News
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 6,444 Shares of Stockthemarketsdaily.com · 9 Oct 2026Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026
1 headline in the last 90 days name Susan Bobulsky; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.